The FY26 Duchenne Muscular Dystrophy Clinical/Translational Research Award supports advanced translational research projects aimed at accelerating promising therapies toward clinical application. It offers two funding levels for preclinical and clinical research and a Partnering PI Option to encourage collaborations between early-career and established investigators, including those transitioning into DMD research. Preliminary data and focus on therapies effective across the lifespan are required.
Open to any type of entity, including early-career and established investigators. Requires preliminary data. Supports partnerships between investigators, including those transitioning into DMD research.
